• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO; SYSTEM, TEST, THYROID AUTOANTIBODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO; SYSTEM, TEST, THYROID AUTOANTIBODY Back to Search Results
Catalog Number 06368590190
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/16/2018
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).
 
Event Description
The customer stated that they received questionable thyroid results for two samples from the same patient tested for multiple thyroid tests on a cobas 8000 e 602 module (e602).Of the mentioned assays, the sample had erroneous results for the elecsys tsh assay (tsh), the elecsys anti-tshr immunoassay (anti-tshr), and roche diagnostics cobas elecsys anti-tpo (anti-tpo).The erroneous results were reported outside of the laboratory.(b)(4).Based on results measured from a sample collected on (b)(6) 2018, the endocrinologist treated the patient with neomercazole treatment starting on (b)(6) 2018.The patient was started with a 60 mg dose at first and then decreased to 40 mg starting on (b)(6) 2018.The endocrinologist stated that the patient had biological basedow disease with no clinical sign.Refer to the attachment for all patient data.The samples, dated (b)(6) 2018 were tested on the e602 analyzer.These samples were also tested using assays manufactured by siemens and brahms.No adverse events were alleged to have occurred with the patient.The patient does not take a dietary supplement.Normally the patient does not take biotin in high doses.The patient has 2 monoclonal immunoglobulins, 1 igg lambda and 1 iga lambda.The e602 analyzer serial number was asked for, but not provided.
 
Manufacturer Narrative
A sample from the patient was provided for investigation.Investigations determined that the sample contains an interferent to a component of the anti-tpo assay.This limitation is covered in product labeling.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination, and other findings.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ROCHE DIAGNOSTICS COBAS ELECSYS ANTI-TPO
Type of Device
SYSTEM, TEST, THYROID AUTOANTIBODY
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key7377996
MDR Text Key104035004
Report Number1823260-2018-00936
Device Sequence Number1
Product Code JZO
Combination Product (y/n)N
PMA/PMN Number
K051890
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number06368590190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Date Manufacturer Received03/02/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FLECAINE; INEXIUM; MONOTILDIEM; NEOMERCAZOLE; PERINDOPRIL; PREVISCAN; TAHOR
Patient Age69 YR
-
-